LIPAC Oncology
Home Platform News Contact
At a glance Leadership Team Careers
PIPELINE NMIBC Malignant Pleural Effusion Ovarian Cancer Intraperitoneal Carcinoma UTUC
Phase 1-2a clinical study
Home About LiPac At a glance Leadership Team Careers Platform Pipeline PIPELINE NMIBC Malignant Pleural Effusion Ovarian Cancer Intraperitoneal Carcinoma UTUC Studies Phase 1-2a clinical study NewsContact
LIPAC Oncology
Huons Licensing Agreement

Articles

NMIBC

Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Joint Guideline 2016

Sanofi Shuts Down Bladder Cancer Drug Production: Inevitable Drug Shortage To Harm Patients 2016

Update on the management of non-muscle invasive bladder cancer - Canadian Urology Association 2010

National Comprehensive Cancer Network

UTUC

Upper Tract Urothelial Carcinoma: Special Considerations 2016

LIPAC Oncology, Inc.
325 Sharon Park Drive, Suite 739, Menlo Park, California, 94025
E-mail: info@lipaconcology.com
About LIPAC
Leadership Team
Pipeline
Platform
Clinical Studies
Privacy Policy | Terms of Use
The LIPAC logo, LIPAC Oncology, PLIP, and LiPax are registered trademarks of LIPAC Oncology © 2019 All Rights Reserved.